Raymond James & Associates’s Cardiol Therapeutics CRDL Stock Holding History

Raymond James & Associates’s Portfolio CRDL Stock Details CRDL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$20.2K	Hold
2023 Q4	$9.4K	Buy